Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma: an analysis of the prospective skin cancer registry ADOREG

Background - The impact of immunosuppressive therapy (IST) on immune-checkpoint inhibition (ICI) is unclear. - Methods - Patients with unresectable advanced melanoma (MM) treated with ICI in the years 2011-2020 were identified from the prospective multicenter German skin cancer registry ADOREG. Pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kochanek, Corinna (VerfasserIn) , Gilde, Catharina (VerfasserIn) , Zimmer, Lisa (VerfasserIn) , Ugurel, Selma (VerfasserIn) , Meier, Friedegund (VerfasserIn) , Utikal, Jochen (VerfasserIn) , Pföhler, Claudia (VerfasserIn) , Herbst, Rudolf (VerfasserIn) , Haferkamp, Sebastian (VerfasserIn) , Welzel, Julia (VerfasserIn) , Dücker, Pia (VerfasserIn) , Leiter, Ulrike (VerfasserIn) , Weichenthal, Michael (VerfasserIn) , von Wasielewski, Imke (VerfasserIn) , Angela, Yenny (VerfasserIn) , Gutzmer, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2024
In: European journal of cancer
Year: 2024, Jahrgang: 198
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.113508
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2023.113508
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804923008109
Volltext
Verfasserangaben:Corinna Kochanek, Catharina Gilde, Lisa Zimmer, Selma Ugurel, Friedegund Meier, Jochen Utikal, Claudia Pföhler, Rudolf Herbst, Sebastian Haferkamp, Julia Welzel, Pia Dücker, Ulrike Leiter, Michael Weichenthal, Imke von Wasielewski, Yenny Angela, Ralf Gutzmer

MARC

LEADER 00000caa a2200000 c 4500
001 1919907696
003 DE-627
005 20251111093441.0
007 cr uuu---uuuuu
008 250317s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2023.113508  |2 doi 
035 |a (DE-627)1919907696 
035 |a (DE-599)KXP1919907696 
035 |a (OCoLC)1528043318 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kochanek, Corinna  |e VerfasserIn  |0 (DE-588)1360233970  |0 (DE-627)1919908064  |4 aut 
245 1 0 |a Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma  |b an analysis of the prospective skin cancer registry ADOREG  |c Corinna Kochanek, Catharina Gilde, Lisa Zimmer, Selma Ugurel, Friedegund Meier, Jochen Utikal, Claudia Pföhler, Rudolf Herbst, Sebastian Haferkamp, Julia Welzel, Pia Dücker, Ulrike Leiter, Michael Weichenthal, Imke von Wasielewski, Yenny Angela, Ralf Gutzmer 
264 1 |c February 2024 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.03.2025 
500 |a Online verfügbar: 28. Dezember 2023, Artikelversion: 5. Januar 2024 
520 |a Background - The impact of immunosuppressive therapy (IST) on immune-checkpoint inhibition (ICI) is unclear. - Methods - Patients with unresectable advanced melanoma (MM) treated with ICI in the years 2011-2020 were identified from the prospective multicenter German skin cancer registry ADOREG. Patients with IST within 60 days before, or within 30 days after start of ICI were compared to patients without IST. End points were disease control rate (DCR), overall survival (OS) and progression-free survival (PFS) determined by Kaplan-Meier method. Prognostic factors were evaluated in a Cox regression model. - Results - Of 814 patients treated with ICI, 73 (9%) received concomitant IST, mainly steroids. Patients with brain metastases (BM) received IST more frequently (n = 34/130 patients; 26%), than patients without BM (39/684 patients; 6%). In patients without BM, IST initiated before, but not IST initiated after start of ICI was significantly associated with worse PFS (univariate hazard ratio (HR) 2.59, 95% confidence interval (95%-CI) 1.07-6.28, p = 0.035; multivariate HR 3.48, 95%-CI 1.26-9.6, p = 0.016). There was no association between IST and OS or DCR. In patients with BM, IST initiated before, but not after start of ICI was significantly associated with worse OS (univariate HR 2.06, 95%-CI 1.07-3.95, p = 0.031; multivariate HR 5.91, 95%-CI 1.74-20.14, p = 0.004). There was no association between IST and PFS or DCR. - Conclusion - Patients receiving IST 60 days before start of ICI showed a tendency to an impaired therapy outcome. IST initiated within 30 days after start of ICI, mainly due to early side effects, did not affect the efficacy of ICI therapy. 
650 4 |a Immune checkpoint inhibition 
650 4 |a Immunosuppression 
650 4 |a Malignant melanoma 
700 1 |a Gilde, Catharina  |e VerfasserIn  |4 aut 
700 1 |a Zimmer, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
700 1 |a Meier, Friedegund  |e VerfasserIn  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
700 1 |a Pföhler, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Herbst, Rudolf  |e VerfasserIn  |4 aut 
700 1 |a Haferkamp, Sebastian  |d 1978-  |e VerfasserIn  |0 (DE-588)132018330  |0 (DE-627)51684296X  |0 (DE-576)298896044  |4 aut 
700 1 |8 1\p  |a Welzel, Julia  |d 1965-  |e VerfasserIn  |0 (DE-588)1111530866  |0 (DE-627)865606919  |0 (DE-576)476150647  |4 aut 
700 1 |a Dücker, Pia  |e VerfasserIn  |4 aut 
700 1 |a Leiter, Ulrike  |e VerfasserIn  |4 aut 
700 1 |a Weichenthal, Michael  |e VerfasserIn  |0 (DE-588)140953272  |0 (DE-627)623003848  |0 (DE-576)321514157  |4 aut 
700 1 |a von Wasielewski, Imke  |e VerfasserIn  |4 aut 
700 1 |a Angela, Yenny  |e VerfasserIn  |4 aut 
700 1 |a Gutzmer, Ralf  |d 1968-  |e VerfasserIn  |0 (DE-588)113713371  |0 (DE-627)502213558  |0 (DE-576)289772095  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 198(2024) vom: Feb., Artikel-ID 113508  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma an analysis of the prospective skin cancer registry ADOREG 
773 1 8 |g volume:198  |g year:2024  |g month:02  |g elocationid:113508  |g extent:8  |a Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma an analysis of the prospective skin cancer registry ADOREG 
856 4 0 |u https://doi.org/10.1016/j.ejca.2023.113508  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804923008109  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250403  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250317 
993 |a Article 
994 |a 2024 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 6 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 60000  |e 60000PU122030923  |k 0/60000/  |p 4 
999 |a KXP-PPN1919907696  |e 4687734650 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.ejca.2023.113508"],"eki":["1919907696"]},"title":[{"subtitle":"an analysis of the prospective skin cancer registry ADOREG","title":"Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma","title_sort":"Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma"}],"recId":"1919907696","note":["Gesehen am 17.03.2025","Online verfügbar: 28. Dezember 2023, Artikelversion: 5. Januar 2024"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"February 2024","dateIssuedKey":"2024"}],"person":[{"given":"Corinna","role":"aut","display":"Kochanek, Corinna","family":"Kochanek","roleDisplay":"VerfasserIn"},{"given":"Catharina","display":"Gilde, Catharina","role":"aut","family":"Gilde","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Zimmer, Lisa","given":"Lisa","family":"Zimmer","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Ugurel","role":"aut","display":"Ugurel, Selma","given":"Selma"},{"roleDisplay":"VerfasserIn","family":"Meier","given":"Friedegund","display":"Meier, Friedegund","role":"aut"},{"role":"aut","display":"Utikal, Jochen","given":"Jochen","family":"Utikal","roleDisplay":"VerfasserIn"},{"family":"Pföhler","roleDisplay":"VerfasserIn","display":"Pföhler, Claudia","role":"aut","given":"Claudia"},{"roleDisplay":"VerfasserIn","family":"Herbst","given":"Rudolf","display":"Herbst, Rudolf","role":"aut"},{"display":"Haferkamp, Sebastian","role":"aut","given":"Sebastian","family":"Haferkamp","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Welzel, Julia","given":"Julia","roleDisplay":"VerfasserIn","family":"Welzel"},{"given":"Pia","role":"aut","display":"Dücker, Pia","family":"Dücker","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Leiter, Ulrike","given":"Ulrike","roleDisplay":"VerfasserIn","family":"Leiter"},{"display":"Weichenthal, Michael","role":"aut","given":"Michael","family":"Weichenthal","roleDisplay":"VerfasserIn"},{"given":"Imke","display":"von Wasielewski, Imke","role":"aut","roleDisplay":"VerfasserIn","family":"von Wasielewski"},{"given":"Yenny","role":"aut","display":"Angela, Yenny","family":"Angela","roleDisplay":"VerfasserIn"},{"given":"Ralf","display":"Gutzmer, Ralf","role":"aut","roleDisplay":"VerfasserIn","family":"Gutzmer"}],"name":{"displayForm":["Corinna Kochanek, Catharina Gilde, Lisa Zimmer, Selma Ugurel, Friedegund Meier, Jochen Utikal, Claudia Pföhler, Rudolf Herbst, Sebastian Haferkamp, Julia Welzel, Pia Dücker, Ulrike Leiter, Michael Weichenthal, Imke von Wasielewski, Yenny Angela, Ralf Gutzmer"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"part":{"extent":"8","year":"2024","volume":"198","text":"198(2024) vom: Feb., Artikel-ID 113508"},"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"disp":"Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma an analysis of the prospective skin cancer registry ADOREGEuropean journal of cancer","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"recId":"266883400","titleAlt":[{"title":"EJC online"}],"pubHistory":["28.1992 -"],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research","roleDisplay":"Herausgebendes Organ"},{"display":"European School of Oncology","role":"isb","roleDisplay":"Herausgebendes Organ"}]}]} 
SRT |a KOCHANEKCOEFFECTSOFA2024